Literature DB >> 7865490

Universal emergence of precore mutant hepatitis B virus along with seroconversion to anti-HBe irrespective of subsequent activity of chronic hepatitis B.

K C Koh1, H S Lee, C Y Kim.   

Abstract

OBJECTIVES: It has been controversial whether or not the emergence of precore mutant HBV is related to the severe form of chronic hepatitis B (CH-B). To further clarify the role of the precore mutant HBV in the natural course of CH-B, we conducted a longitudinal analysis of precore-region sequences according to the biochemical severity along with seroconversion to anti-HBe in patients with CH-B.
METHODS: The precore sequences of the ten sets of serial serum samples, obtained from 6 chronic hepatitis B patients with (group I) and from 4 patients without subsequent biochemical remission after seroconversion to anti-HBe (group II), were analyzed by direct sequencing of DNA amplified by PCR.
RESULTS: The precore mutant HBV having a G-A mutation at the nucleotide 1896 was most commonly found (9/10). Wild-type precore HBV was detected in 4 of 6 (66.7%) in group I and 3 of 4 (75.0%) in group II during HBeAg-positive period (p > 0.05), and during anti-HBe-positive period it was found in 2 of 6 (33.3%) in group I and 0 of 4 (0%) in group II (p > 0.05). In contrast, precore mutant HBV was detected in 5 of 6 (83.3%) in group I and 2 of 4 (50.0%) in group II during HBeAg-positive period (p > 0.05), and in all patients of both groups during anti-HBe-positive period.
CONCLUSION: The most common type of precore mutant HBV in Korea was the mutant with a G-A mutation at nucleotide 1896. The emergence of precore mutant HBV was a universal phenomenon during the natural history of CH-B; therefore, the precore mutant does not appear to have an pathogenic role in determining the severity of the CH-B.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7865490      PMCID: PMC4532063          DOI: 10.3904/kjim.1994.9.2.61

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  30 in total

1.  Efficient purification of PCR products using ultrafiltration.

Authors:  A M Krowczynska; M B Henderson
Journal:  Biotechniques       Date:  1992-08       Impact factor: 1.993

2.  Replication capacities of natural and artificial precore stop codon mutants of hepatitis B virus: relevance of pregenome encapsidation signal.

Authors:  S P Tong; J S Li; L Vitvitski; C Trépo
Journal:  Virology       Date:  1992-11       Impact factor: 3.616

3.  Expression of the precore region of an avian hepatitis B virus is not required for viral replication.

Authors:  C Chang; G Enders; R Sprengel; N Peters; H E Varmus; D Ganem
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

4.  Active and inactive replication of hepatitis B virus deoxyribonucleic acid in chronic liver disease.

Authors:  O Yokosuka; M Omata; F Imazeki; K Okuda
Journal:  Gastroenterology       Date:  1985-09       Impact factor: 22.682

5.  Active hepatitis B virus replication in the presence of anti-HBe is associated with viral variants containing an inactive pre-C region.

Authors:  S P Tong; J S Li; L Vitvitski; C Trépo
Journal:  Virology       Date:  1990-06       Impact factor: 3.616

6.  Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus.

Authors:  S J Hadziyannis; H M Lieberman; G G Karvountzis; D A Shafritz
Journal:  Hepatology       Date:  1983 Sep-Oct       Impact factor: 17.425

7.  Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region.

Authors:  J S Li; S P Tong; Y M Wen; L Vitvitski; Q Zhang; C Trépo
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

8.  Low prevalence of precore mutations in hepatitis B virus DNA in fulminant hepatitis type B in France.

Authors:  C Féray; M Gigou; D Samuel; J Bernuau; H Bismuth; C Bréchot
Journal:  J Hepatol       Date:  1993-04       Impact factor: 25.083

9.  Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe.

Authors:  F Bonino; F Rosina; M Rizzetto; R Rizzi; E Chiaberge; R Tardanico; F Callea; G Verme
Journal:  Gastroenterology       Date:  1986-05       Impact factor: 22.682

10.  Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen.

Authors:  A Penna; F V Chisari; A Bertoletti; G Missale; P Fowler; T Giuberti; F Fiaccadori; C Ferrari
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

View more
  2 in total

1.  Hepatitis B in childhood: An update for the paediatrician.

Authors:  L T Yeung; E A Roberts
Journal:  Paediatr Child Health       Date:  2001-11       Impact factor: 2.253

2.  Association of the core clustering mutations (codon 21-34) and the severity of chronic hepatitis B in Korean patients.

Authors:  K C Koh; H S Lee; C Y Kim
Journal:  Korean J Intern Med       Date:  1995-07       Impact factor: 2.884

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.